Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Monk

Showing results (11-20 of 738) with videos related to

Pageof 74
Sort By:
Journal of the American Chemical Society|September 16, 2004
Fabrication of gold microtubes and microwires in high aspect ratio capillary arraysDavid J Monk, David R Walt
Current Oncology Reports|October 14, 2005
Gynecologic oncology group trials of chemotherapy for metastatic and recurrent cervical cancerKrishnansu S Tewari, Bradley J Monk
Obstetrics and Gynecology|August 1, 1992
Invasive cervical cancer complicating intrauterine pregnancy: treatment with radical hysterectomyB J Monk, F J Montz
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|December 4, 2009
Changing the paradigm in the treatment of platinum-sensitive recurrent ovarian cancer: from platinum doublets to nonplatinum doublets and adding antiangiogenesis compoundsBradley J Monk, Robert L Coleman
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 13, 2017
Is intraperitoneal chemotherapy still an acceptable option in primary adjuvant chemotherapy for advanced ovarian cancer?B J Monk, J K Chan
Gynecologic Oncology|April 6, 2010
Bevacizumab toxicities and their management in ovarian cancerLeslie M Randall, Bradley J Monk
Clinical and Experimental Dermatology|March 1, 1991
Talar callosity--a little-recognized common entityJ L Verbov, C J Monk
Expert Review of Anticancer Therapy|July 11, 2009
Systemic therapy for recurrent endometrial cancer: a review of North American trialsThanh H Dellinger, Bradley J Monk
Clinical Advances in Hematology & Oncology : H&O|April 14, 2010
The rationale for the use of non-platinum chemotherapy doublets for metastatic and recurrent cervical carcinomaKrishnansu Sujata Tewari, Bradley J Monk
Gynecologic Oncology|May 24, 2008
The spectrum and clinical sequelae of human papillomavirus infectionBradley J Monk, Krishnansu S Tewari
Pageof 74

Showing results (11-20 of 738) with videos related to

Sort By:
Pageof 74
Journal of the American Chemical Society|September 16, 2004
Fabrication of gold microtubes and microwires in high aspect ratio capillary arraysDavid J Monk, David R Walt
Current Oncology Reports|October 14, 2005
Gynecologic oncology group trials of chemotherapy for metastatic and recurrent cervical cancerKrishnansu S Tewari, Bradley J Monk
Obstetrics and Gynecology|August 1, 1992
Invasive cervical cancer complicating intrauterine pregnancy: treatment with radical hysterectomyB J Monk, F J Montz
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|December 4, 2009
Changing the paradigm in the treatment of platinum-sensitive recurrent ovarian cancer: from platinum doublets to nonplatinum doublets and adding antiangiogenesis compoundsBradley J Monk, Robert L Coleman
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 13, 2017
Is intraperitoneal chemotherapy still an acceptable option in primary adjuvant chemotherapy for advanced ovarian cancer?B J Monk, J K Chan
Gynecologic Oncology|April 6, 2010
Bevacizumab toxicities and their management in ovarian cancerLeslie M Randall, Bradley J Monk
Clinical and Experimental Dermatology|March 1, 1991
Talar callosity--a little-recognized common entityJ L Verbov, C J Monk
Expert Review of Anticancer Therapy|July 11, 2009
Systemic therapy for recurrent endometrial cancer: a review of North American trialsThanh H Dellinger, Bradley J Monk
Clinical Advances in Hematology & Oncology : H&O|April 14, 2010
The rationale for the use of non-platinum chemotherapy doublets for metastatic and recurrent cervical carcinomaKrishnansu Sujata Tewari, Bradley J Monk
Gynecologic Oncology|May 24, 2008
The spectrum and clinical sequelae of human papillomavirus infectionBradley J Monk, Krishnansu S Tewari
Pageof 74